Bond Screener
Immucor
LEI 549300CSHW546WORC082
Organization name
Immucor Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
-
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Immucor Inc. and its subsidiaries develop, manufacture, and sell reagents and automated systems used primarily by hospitals, clinical labs, and blood banks in tests to detect and identify certain properties of the cell and serum components of human blood before blood transfusions.
|
General information
-
Organization nameImmucor Inc.
-
Organization statusOperating organization
-
Address3130 Gateway Drive Norcross, USA, 30071
-
Site
IFRS/US GAAP reports
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show all
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameImmucor Inc.
-
Organization statusOperating organization
-
Address3130 Gateway Drive Norcross, USA, 30071
-
Site
Codes
-
LEI549300CSHW546WORC082
-
SIC2835 IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
-
NACE*** ***
-
NAICS*** ***
-
CIK0000736822
